An even greater challenge is their need for external investment. During the early stages of development, in order to progress ...

After hours: March 19 at 7:09:14 PM EDT Loading Chart for BLRX ...

通过将阿糖胞苷荧光标记，可以追踪其在细胞内的分布和代谢过程。这对于研究细胞增殖、分化以及药物作用机制等方面具有重要意义。 荧光成像技术可以实时监测阿糖胞苷在活细胞中的动态变化，为药物筛选和疗效评估提供有力工具。 药物代谢研究： 阿糖胞 ...

Marlise R. Luskin, MD, MSCE, discussed treatment options for blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and challenging disease.

These nucleosides provided the inspiration for the chemotherapy drug cytarabine, which is among the WHO's List of Essential Medicines for its use in treating non-Hodgkin's lymphoma and leukemia.

In March 2025, Akeso initiated an open-label, Phase Ib/II study involving patients diagnosed with acute myeloid leukemia (AML ...

Actimab-A is a humanized anti-CD33 antibody conjugated to Actinium-225 (Ac-225). With its potent alpha-particle payload ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with a broad ...

Clinical trial design is a key aspect of the successful conduct of clinical trials. It involves deciding parameters such as the number of patients, the length of the trial, the comparator arm (in ...

alloHCT, allogeneic hematopoietic cell transplantation; aPTT, activated partial thromboplastin time; DIC, disseminated intravascular coagulation; FLAMSA-RIC, sequential conditioning regimen ...

Haematological diseases are pathological conditions primarily affecting the blood or blood-producing organs. This group of disorders includes, but is not limited to, various types of anaemia ...